We use cookies for a better user experience. Read our Privacy Policy

I Agree

Asthma Spacers Market

Asthma Spacers Market (Product Type - Aerochamber, Optichamber, Volumatic, Inspirease; Distribution Channel - Retail Pharmacy, Hospital Pharmacy, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 - 2026

There is little contention about the importance of asthma spacers for people suffering from various degrees of the pulmonary disease. The direct relationship between proper breathing and healthy lungs has compelled medical practitioners and researchers to invest time and resources in treating pulmonary diseases. The permanent need for asthma spacers in critically ill patients has created increased demand within the global market.

  • Over the past decade, changing propensities and lifestyles of the masses have led to an increase in the incidence of asthma and other lung disorders. In addition to this, medical researchers have witnessed a decline in the immunity levels of the masses over the past few years. Considering the factors stated above, the demand within the global asthma spacers market is projected to rise in the years to follow.
  • The National Asthma Council, Australia has released crucial information related to the use of asthma spacers. The council describes the shape and specifications of an ideal asthma spacer. Moreover, the ease of using these spacers has also been enunciated by the council. COPD or asthma medication can be easily administered with the help of these spacers. A metered dose inhaler is often attached with these spacers in order to ease inhalation. The total demand for these spacers has increased by a dramatic chase in recent times.

Spacers help in coordinating the processes of pressing the puffer and breathing in. This is also an important factor responsible for the growth of the global asthma spacers market. Over the course of the next decade, several new technologies are expected to make way into the medical industry. Moreover, investments in development of high-end spacers and technologies have also gained prominence in recent times. The revenue index of the global asthma spacers market is expected to improve in the years to follow.

Asthma Spacers Market - Snapshot

Asthma is a chronic respiratory condition that affects millions of people around the world. Aerosol drug delivery is the first line administration route in asthma management, and metered dose inhalers (MDIs) are the most common type of inhalers used in asthmatic conditions. However, poor inhalation techniques have led to poor control of asthma. Valve holding chambers/spacers are designed to counter the problem. A spacer, usually attached with an MDI, is an external device that provides better drug delivery by increasing inhalation and actuation. The global asthma spacers market was valued at US$ 1,330.56 Mn in 2017. It is expected to expand at a CAGR of 3.7% from 2018 to 2026.

asthma spacers market

Spacers with metered dose inhalers are used to treat several respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Technological advancements in spacer devices is likely to propel the market in the near future.

The global asthma spacers market can be segmented based on product type, distribution channel, and geography. In terms of product type, the market can be divided into aerochamber, optichamber, volumatic, inspirease, and others. The aerochamber segment is likely to account for a leading share of the global market during the forecast period, owing to the wide adoption of these devices for the management of asthma. Technological developments in aerochambers are estimated to boost the segment during the forecast period. Based on distribution channel, the asthma spacers market can be classified into retail pharmacy, hospital pharmacy, and e-commerce. The retail pharmacy segment is expected to hold a significant share of the global asthma spacers market, due to a rise in over-the-counter sales of asthma spacers with metered dose inhalers.

In terms of geography, the global asthma spacers market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America and Europe accounted for a major share of the global market in 2017. High prevalence of asthma, favorable reimbursement policies, and increase in government initiatives that mandate the use of asthma spacers with metered dose inhalers are driving demand for asthma spacers in these regions. The asthma spacers market in Asia Pacific is likely to expand at a significant CAGR during the forecast period. A large asthmatic population with poorly controlled symptoms and rise in health care expenditure are projected to fuel the market in the region in the coming years. Moreover, low cost of manufacturing in China and India has resulted in a rise in the number of production facilities in the countries, attracting key players to the region from across the world.

Key players operating in the global asthma spacers market include Trudell Medical Internationa, Pari Gmbh, GlaxoSmihKline plc, Medical Development International, Cipla, Lupin, Clement Clarke, AstraZeneca, Merck & Co., and Fisons. These companies have established themselves in the market and enjoy brand loyalty among customers. They have a diverse product offering and an extensive distribution system across the world. Also, entry of small players is high, especially in emerging regions of the market such as Asia. However, high quality standards set by market leaders are anticipated to restrain the penetration of new entrants in the market.

Growing Clinical Acceptance of Inhaled Therapies Boosts Asthma Spacers Market

The drive for asthma spaces market stems from the widespread acceptance of pressurized metered-dose inhaler (MDI) in the pharmacological management of asthma. The benefit/risk ratio and tolerability are the key attributes propelling the popularity of use of MDI, which, in turn is propelling the prospects in the asthma spacers market. The concerns of the incorrect usage of MDI have been at the forefront in driving the evolution of the asthma spacers market. Growing number of patients with COPD and asthma who need critical care is a key trend bolstering the clinical need for spacer technologies. The asthma spacers market has also benefitted from the advancements made in mechanism of valved holding chambers. Most commonly, aerosol drug delivery is used in MDI using asthma spacers. Over the past few years, the asthma spacers market has been witnessing new growth avenues due to the increased focus on reducing the side-effects of asthma drugs. A case in point is reducing the impact of corticosteroids, since they lead to oral candidiasis.

In the times when coronavirus disease 2019 (COVID-19) has led to severe health pandemic, valved-holding chambers (VHCs). Thus, though the pandemic-led lockdowns have crippled economies and healthcare systems, there also has been surge in demand for medical devices, equipment, and consumables that are used in the management of the symptoms. The high transmissibility of the virus provides a robust ground for the adoption of asthma spacers. Many countries have stressed on discontinuation of small-volume nebulizers (SVNs) and adopt asthma spacers. However, in some countries where healthcare systems are quite costly for a large percentage of population, reimbursement plays a crucial factor in decision-making. On the other hand, researchers are accumulating evidence on the role of asthma spacers on decreasing early readmission. The presence of a large percentage of asymptomatic COVID-19 patients has also made it necessary for patients to embrace asthma spacers, thereby favoring the opportunity in the asthma spacers market.

The global asthma spacers market has been segmented as below:

Product Type

  • Aerochamber
  • Optichamber
  • Volumatic
  • Inspirease
  • Others

Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy
  • E-commerce

Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • Saudi Arabia
    • Israel
    • Rest of Middle East & Africa
Asthma Spacers Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions and Acronyms Used
     2.2. Research Methodology

3. Executive Summary
     3.1. Global Asthma Spacers Market: Market Snapshot

4. Market Overview
     4.1. Global Asthma Spacers Market: Product Overview 
     4.2. Global Asthma Spacers Market: Key Industry Developments
     4.3. Market Dynamics
            4.3.1. Drivers
            4.3.2. Restraints
            4.3.3. Opportunities
     4.4. Global Asthma Spacers Market Revenue Projections, 2016–2026
     4.5. Porter’s Five Forces Analysis
     4.6. Global Asthma Spacers Market Outlook

5. Market Outlook
     5.1. Key Mergers and Acquisitions
     5.2. Key Market Trends
     5.3. Pricing Analysis: Different Asthma Spacers
     5.4. Strategies Adopted by Top Three Players

6. Global Asthma Spacers Market Analysis, by Product Type
     6.1. Key Findings
     6.2. Introduction
     6.3. Global Asthma Spacers Market Value Share and Attractiveness Analysis, by Product Type
     6.4. Global Asthma Spacers Market Value Forecast, by Product Type
                   6.4.1. Aerochamber
            6.4.2. Optichamber
            6.4.3. Volumatic
            6.4.4. Inspirease
            6.4.5. Others
     6.5. Global Asthma Spacers Market Analysis, by Product Type

7. Global Asthma Spacers Market Analysis, by Distribution Channel
     7.1. Key Findings
     7.2. Introduction
     7.3. Global Asthma Spacers Market Value Share and Attractiveness Analysis, by Distribution Channel
     7.4. Global Asthma Spacers Market Value Forecast, by Distribution Channel
            7.4.1. Retail Pharmacy
            7.4.2. Hospital Pharmacy
            7.4.3. E-commerce
     7.5. Global Asthma Spacers Market Analysis, by Distribution Channel

8. Global Asthma Spacers Market Analysis, by Region
     8.1. Global Asthma Spacers Market Scenario, by Country
     8.2. Global Asthma Spacers Market Value Share and Attractiveness Analysis, by Region
     8.3. Global Asthma Spacers Market Value Forecast, by Region
            8.3.1. North America
            8.3.2. Europe
            8.3.3. Asia Pacific 
            8.3.4. Latin America
            8.3.5. Middle East & Africa

9. North America Asthma Spacers Market Analysis
     9.1. Key Findings
     9.2. North America Asthma Spacers Market Overview
     9.3. North America Asthma Spacers Market Value Share and Attractiveness Analysis, by Country
     9.4. North America Asthma Spacers Market Forecast, by Country
            9.4.1. U.S.
            9.4.2. Canada
     9.5. North America Asthma Spacers Market Value Share Analysis, by Product Type
     9.6. North America Asthma Spacers Market Forecast, by Product Type
            9.6.1. Aerochamber
            9.6.2. Optichamber
            9.6.3. Volumatic
            9.6.4. Inspirease
            9.6.5. Others
     9.7. North America Asthma Spacers Market Value Share Analysis, by Distribution Channel
     9.8. North America Asthma Spacers Market Forecast, by Distribution Channel
            9.8.1. Retail Pharmacy
            9.8.2. Hospital Pharmacy
            9.8.3. E-commerce
     9.9. North America Asthma Spacers Market Attractiveness Analysis

10. Europe Asthma Spacers Market Analysis
     10.1. Key Findings
     10.2. Europe Asthma Spacers Market Overview
     10.3. Europe Asthma Spacers Market Value Share and Attractiveness Analysis, by Country/Sub-region
     10.4. Europe Asthma Spacers Market Forecast, by Country/Sub-region
            10.4.1. Germany
            10.4.2. U.K.
            10.4.3. France
            10.4.4. Italy
            10.4.5. Spain
            10.4.6. Rest of Europe
     10.5. Europe Asthma Spacers Market Value Share Analysis, by Product Type
     10.6. Europe Asthma Spacers Market Forecast, by Product Type
            10.6.1. Aerochamber
            10.6.2. Optichamber
            10.6.3. Volumatic
            10.6.4. Inspirease
            10.6.5. Others
     10.7. Europe Asthma Spacers Market Value Share Analysis, by Distribution Channel
     10.8. Europe Asthma Spacers Market Forecast, by Distribution Channel
            10.8.1. Retail Pharmacy
            10.8.2. Hospital Pharmacy
            10.8.3. E-commerce
     10.9. Europe Asthma Spacers Market Attractiveness Analysis

11. Asia Pacific Asthma Spacers Market Analysis
     11.1. Key Findings
     11.2. Asia Pacific Asthma Spacers Market Overview
     11.3. Asia Pacific Asthma Spacers Market Value Share and Attractiveness Analysis, by Country/Sub-region
     11.4. Asia Pacific Asthma Spacers Market Forecast, by Country/Sub-region
            11.4.1. China
            11.4.2. India
            11.4.3. Japan
            11.4.4. Australia & New Zealand
            11.4.5. Rest of Asia Pacific
     11.5. Asia Pacific Asthma Spacers Market Value Share Analysis, by Product Type
     11.6. Asia Pacific Asthma Spacers Market Forecast, by Product Type
                   11.6.1. Aerochamber
            11.6.2. Optichamber
            11.6.3. Volumatic
            11.6.4. Inspirease
            11.6.5. Others
     11.7. Asia Pacific Asthma Spacers Market Value Share Analysis, by Distribution Channel
     11.8. Asia Pacific Asthma Spacers Market Forecast, by Distribution Channel
            11.8.1. Retail Pharmacy
            11.8.2. Hospital Pharmacy
            11.8.3. E-commerce
     11.9. Asia Pacific Asthma Spacers Market Attractiveness Analysis

12. Latin America Asthma Spacers Market Analysis
     12.1. Key Findings
     12.2. Latin America Asthma Spacers Market Overview
     12.3. Latin America Asthma Spacers Market Value Share and Attractiveness Analysis, by Country/Sub-region
     12.4. Latin America Asthma Spacers Market Forecast, by Country/Sub-region
            12.4.1. Brazil
            12.4.2. Mexico
            12.4.3. Rest of Latin America
     12.5. Latin America Asthma Spacers Market Value Share Analysis, by Product Type
     12.6. Latin America Asthma Spacers Market Forecast, by Product Type
            12.6.1. Aerochamber
            12.6.2. Optichamber
            12.6.3. Volumatic
            12.6.4. Inspirease
            12.6.5. Others
     12.7. Latin America Asthma Spacers Market Value Share Analysis, by Distribution Channel
     12.8. Latin America Asthma Spacers Market Forecast, by Distribution Channel
            12.8.1. Retail Pharmacy
            12.8.2. Hospital Pharmacy
            12.8.3. E-commerce
     12.9. Latin America Asthma Spacers Market Attractiveness Analysis

13. Middle East & Africa Asthma Spacers Market Analysis
     13.1. Key Findings
     13.2. Middle East & Africa Asthma Spacers Market Overview
     13.3. Middle East & Africa Asthma Spacers Market Value Share Analysis, by Country/Sub-region
     13.4. Middle East & Africa Asthma Spacers Market Forecast, by Country/Sub-region
            13.4.1. GCC Countries
            13.4.2. Saudi Arabia
            13.4.3. Israel
            13.4.4. Rest of Middle East & Africa
     13.5. Middle East & Africa Asthma Spacers Market Value Share Analysis, by Product Type
     13.6. Middle East & Africa Asthma Spacers Market Forecast, by Product Type
            13.6.1. Aerochamber
            13.6.2. Optichamber
            13.6.3. Volumatic
            13.6.4. Inspirease
            13.6.5. Others
     13.7. Middle East & Africa Asthma Spacers Market Value Share Analysis, by Distribution Channel
     13.8. Middle East & Africa Asthma Spacers Market Forecast, by Distribution Channel
            13.8.1. Retail Pharmacy
            13.8.2. Hospital Pharmacy
            13.8.3. E-commerce
     13.9. Middle East & Africa Asthma Spacers Market Attractiveness Analysis

14. Competition Landscape
     14.1. Asthma Spacers Market Share Analysis, by Company, 2017
     14.2. Competition Matrix
     14.3. Company Profiles
            14.3.1. Trudell Medical International
                     14.3.1.1. Company Details
                     14.3.1.2. Business Overview
                     14.3.1.3. Financial Overview
                     14.3.1.4. Strategic Overview
                     14.3.1.5. SWOT Analysis
            14.3.2. PARI GmbH
                     14.3.2.1. Company Details
                     14.3.2.2. Business Overview
                     14.3.2.3. Financial Overview
                     14.3.2.4. Strategic Overview
                     14.3.2.5. SWOT Analysis
            14.3.3. GlaxoSmithKline plc
                     14.3.3.1. Company Details
                     14.3.3.2. Business Overview
                     14.3.3.3. Financial Overview
                     14.3.3.4. Strategic Overview
                     14.3.3.5. SWOT Analysis
            14.3.4. CONMED Corporation
                     14.3.4.1. Company Details
                     14.3.4.2. Business Overview
                     14.3.4.3. Financial Overview
                     14.3.4.4. Strategic Overview
                     14.3.4.5. SWOT Analysis
            14.3.5. Medical Developments International
                     14.3.5.1. Company Details
                     14.3.5.2. Business Overview
                     14.3.5.3. Financial Overview
                     14.3.5.4. Strategic Overview
                     14.3.5.5. SWOT Analysis
            14.3.6. Koninklijke Philips N.V
                     14.3.6.1. Company Details
                     14.3.6.2. Business Overview
                     14.3.6.3. Financial Overview
                     14.3.6.4. Strategic Overview
                     14.3.6.5. SWOT Analysis
            14.3.7. Merck & Co., Inc
                     14.3.7.1. Company Details
                     14.3.7.2. Business Overview
                     14.3.7.3. Financial Overview
                     14.3.7.4. Strategic Overview
                     14.3.7.5. SWOT Analysis
            14.3.8. AstraZeneca
                     14.3.8.1. Company Details
                     14.3.8.2. Business Overview
                     14.3.8.3. Financial Overview
                     14.3.8.4. Strategic Overview
                     14.3.8.5. SWOT Analysis
            14.3.9. Overview of other Prominent Players

List of Tables

Table 01: Key Merger and Acquisitions
Table 02: Global Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 03: Global Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 04: Global Asthma Spacers Market Size (US$ Mn) Forecast, by Region, 2016–2026
Table 05: North America Asthma Spacers Market Size (US$ Mn) Forecast, by Country, 2016–2026
Table 06: North America Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 07: North America Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 08: Europe Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region 2016–2026
Table 09: Europe Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 10: Europe Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 11: Asia Pacific Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region 2016–2026
Table 12: Asia Pacific Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 13: Asia Pacific Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 14: Latin America Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 15: Latin America Asthma Spacers Market Size (US$ Mn) Forecast, by Product, 2016–2026
Table 16: Latin America Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 17: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
Table 18: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast, by Product Type, 2016–2026
Table 19: Middle East & Africa Asthma Spacers Market Size (US$ Mn) Forecast, by Distribution Channel, 2016–2026
Table 20: Trudell Medical International Product Offerings
Table 21: Pari GmbH Product Offerings
Table 22: GlaxoSmithKline plc. Product Offerings
Table 23: Medical Developments International Product Offerings
Table 24: Koninklijke Philips N.V Product Offerings
Table 25: Merck & Co., Inc Product Offerings
Table 26: AstraZeneca Product Offerings
Table 27: Overview of Other Prominent Players

List of Figures

Figure 01: Global Asthma Spacers Market Value (US$ Mn) and Distribution, by Region, 2018 and 2026
Figure 02: Revenue Share, 2017
Figure 03: Global Asthma Spacers Market Revenue Projection (US$ Mn), 2016–2026
Figure 05: Global Asthma Spacer Market Value Share, by Distribution Channel, 2017
Figure 04: Global Asthma Spacers Market Value Share, by Product Type, 2017
Figure 06: Global Asthma Spacer Market Value Share,
Figure 07: Top 3 Players operating in Market Space
Figure 08: Global Asthma Spacers Market Value Share Analysis, by Product Type, 2018 and 2026
Figure 09: Global Asthma Spacers Market Attractiveness, by Product Type, 2018–2026
Figure 10: Global Asthma Spacers Market Value (US$ Mn) and Y-o-Y Growth, by Aerochamber, 2016–2026
Figure 11: Global Asthma Spacers Market Value (US$ Mn) and Y-o-Y Growth, by Optichamber, 2016–2026
Figure 12: Global Asthma Spacers Market Value (US$ Mn) and Y-o-Y Growth, by Volumatic, 2016–2026
Figure 13: Global Asthma Spacers Market Value (US$ Mn) and Y-o-Y Growth, by Inspirease, 2016–2026
Figure 14: Global Asthma Spacers Market Value (US$ Mn) and Y-o-Y Growth, by Others, 2016–2026
Figure 15: Global Asthma Spacers Market Value Share, by Distribution Channel, 2017 and 2026
Figure 16: Global Asthma Spacers Market Attractiveness, by Distribution Channel, 2018–2026
Figure 17: Global Asthma Spacers Market Revenue
Figure 18: Global Asthma Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospital Pharmacy, 2016–2026
Figure 19: Global Asthma Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection,   by E-commerce, 2016-2026
Figure 20: Global Asthma Spacers Market Value Share, by Region, 2017 and 2026 
Figure 21: Global Asthma Spacers Market Attractiveness, by Region, 2018–2026
Figure 22: North America Asthma Spacers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2018–2026
Figure 23: North America Asthma Spacers Market Value Share Analysis, by Country, 2017 and 2026
Figure 24: North America Asthma Spacers Market Attractiveness Analysis, by Country, 2018-2026
Figure 25: North America Asthma Spacers Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 26: North America Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 27: North America Asthma Spacers Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 28: North America Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 29: Europe Asthma Spacers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 30: Europe Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 31: Europe Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 32: Europe Asthma Spacers Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 33: Europe Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 34: Europe Asthma Spacers Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 35: Europe Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 36: Asia Pacific Asthma Spacers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 37: Asia Pacific Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 38: Asia Pacific Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 39: Asia Pacific Asthma Spacers Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 40: Asia Pacific Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 41: Asia Pacific Asthma Spacers Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 42: Asia Pacific Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 43: Latin America Asthma Spacers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 44: Latin America Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 45: Latin America Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2018-2026
Figure 46: Latin America Asthma Spacers Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 47: Latin America Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 48: Latin America Asthma Spacers Market Attractiveness Analysis, by Product, 2018–2026
Figure 49: Latin America Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 50: Middle East & Africa Asthma Spacers Market Size (US$ Mn) and Y-o-Y Growth (%) Forecast, 2016–2026
Figure 51: Middle East & Africa Asthma Spacers Market Value Share Analysis, by Country/Sub-region, 2017 and 2026
Figure 52: Middle East & Africa Asthma Spacers Market Attractiveness Analysis, by Country/Sub-region, 2018–2026
Figure 53: Middle East & Africa Asthma Spacers Market Value Share Analysis, by Product Type, 2017 and 2026
Figure 54: Middle East & Africa Asthma Spacers Market Value Share Analysis, by Distribution Channel, 2017 and 2026
Figure 55: Middle East & Africa Asthma Spacers Market Attractiveness Analysis, by Product Type, 2018–2026
Figure 56: Middle East & Africa Asthma Spacers Market Attractiveness Analysis, by Distribution Channel, 2018–2026
Figure 57: Global Asthma Spacers Market Share Analysis, by Key Player (2016)
Figure 58: GlaxoSmithKline plc.  Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017
Figure 59: GlaxoSmithKline plc. R&D Spending on Total Revenue (%), 2016–2017
Figure 60: GlaxoSmithKline plc. Breakdown of Net Sales, by Region, 2017
Figure 61: GlaxoSmithKline plc. Breakdown of Net Sales, by Business Segment, 2017
Figure 62: Medical Developments International Revenue (US$ Thousands) and Y-o-Y Growth (%), 2014–2017
Figure 63: Medical Developments International R&D Spending (%) on Total Revenue, 2016–2017
Figure 64: Medical Developments International Breakdown of Net Sales, by Region, 2017
Figure 65: Medical Developments International Breakdown of Net Sales, by Business Segment, 2017
Figure 66: Koninklijke Philips N.V Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2017
Figure 67: Koninklijke Philips N.V R&D Spending (%) on Total Revenue, 2016–2017
Figure 68: Koninklijke Philips N.V Breakdown of Net Sales, by Region, 2017
Figure 69: Koninklijke Philips N.V Breakdown of Net Sales, by Business Segment, 2017
Figure 70: Merck & Co., Inc Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 71: Merck & Co., Inc Breakdown of Net Sales, by Region, 2017
Figure 72: AstraZeneca Revenue (US$ Mn) & Y-o-Y Growth (%), 2014–2017
Figure 73: AstraZeneca Breakdown of Net Sales, by Region, 2017

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

305

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved